Bellevue Group’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$232K Buy
2025
Q2
$172K Sell
2025
Q1
$478K Sell
2024
Q4
$791K Buy
2024
Q3
$870K Buy
2024
Q2
$771K Sell
2024
Q1
$856K Sell
2023
Q4
$992K Sell
2023
Q3
$1.45M Sell
2023
Q2
$2.11M Sell
2023
Q1
$1.47M Hold
2022
Q4
$1.45M Hold
2022
Q3
$1.28M Buy
2022
Q2
$880K Sell
2022
Q1
$918K Sell
2021
Q4
$979K Buy